Table 1.

Articles published as part of the current research topic.

#	Journal	Title	Ref.
1	FO	Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD–(L)1 inhibitors	(3)
2	FI	Elucidation of the application of blood test biomarkers to predict immune–related adverse events (irAEs) in atezolizumab–treated NSCLC patients by using machine learning methods	(4)
3	FO	The prominent role of the S100A8/S100A9–CD147 axis in the progression of penile cancer	(5)
4	FI	A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma	(6)
5	FI	The HSP Immune Network in Cancer	(7)
6	FI	m6A modification patterns with distinct immunity, metabolism, and stemness characteristics in soft tissue sarcoma	(8)
7	FI	Immune Checkpoint Inhibitor–Induced Cerebral Pseudoprogression: Patterns and Categorization	(9)
8	FI	Human papillomavirus infection can alter the level of tumour stemness and T cell infiltration in patients with head and neck squamous cell carcinoma	(10)
9	FI	Phenotypic and functional analysis of γδ T cells in the pathogenesis of human T–cell lymphotropic virus type 1 infection	(11)
10	FI	Systemic immune dysregulation correlates with clinical features of early NSCLC	(12)
11	FI	Picturing of the lung tumor cellular composition by multispectral flow cytometry	(13)
12	FI	Characterization of the immune cell landscape in CRC: clinical implications of tumour–infiltrating leukocytes in early– and late–stage CRC	(14)
13	FI	Sarcoidosis following Hematopoietic Stem Cell Transplantation: clinical characteristics and HLA associations	(15)
14	FI	Utility and drawbacks of Chimeric Antigen Receptor T cell (CAR–T) therapy in lung cancer	(16)

FI, Frontiers in Immunology; FO, frontiers in Oncology.